No clinically significant differences in patient-reported outcome measures across total hip arthroplasty approaches.
Andrew G KimAdam A RizkAustin M ChiuWilliam ZukeAlexander J AcuñaTarun K JellaPublished in: Hip international : the journal of clinical and experimental research on hip pathology and therapy (2023)
Superiority of any 1 approach could not be concluded based on the mixed findings of the present analysis. Although our pooled analysis found no significant differences in outcomes except for those measured by the EQ-5D index, a few additional metrics, notably the WOMAC, HHS, FJS-12, and VAS-pain scores, leaned in favour of the DAA.